New Product line for Clinical Diagnostics

ProGnosis Biotech made the first step in the Clinical Diagnostics field with Rapid Test Ag 2019 n-CoV and is now is lauching the new additions to its catalog.

A whole new line of Clinical Diagnostics is available to offer solution for the ongoing battle against viruses. Our new Rapid Tests can detect, with high specificity and sensitivity, the presence of specific viral antigens, indicative of

The new products include:

• Combo Rapid Test that differentiates between SARS-CoV-2 virus (COVID-19) and the Flu (influenza A&B).

• Flu Rapid Test that differentiates between Influenza A and Influenza B.

• Rapid Test that detects Adenoviruses that cause respiratory illness

• Rapid Test that detects the Respiratory Syncytial Virus (RSV).

Learn more about them by clicking here

Share This Post

More To Explore

90th International Agricultural Fair NoviSad

Prognosis Biotech recently participated in the 90th International Agricultural Fair in Novi Sad from May 23rd to 25th. We showcased our innovative mycotoxin detection technology,